logo
Plus   Neg
Share
Email

Basilea Reaches Agreement With Roche On Planned Study In Gastric Cancer

Basilea Pharmaceutica said Wednesday that it extended its clinical supply agreement with Roche to explore a combination of Basilea's panFGFR kinase inhibitor derazantinib and Roche's atezolizumab in patients with gastric (stomach) cancer.

The initial clinical supply agreement covered urothelial (bladder) cancer and was concluded in January 2019.

Basilea expects to start a biomarker-driven multi-cohort phase 1/2 study in advanced gastric cancer patients with FGFR genetic aberrations in the third quarter of 2020. The study will assess the efficacy and safety of derazantinib as mono- and combination therapy in the second-line setting.

Basilea will be the sponsor of the study and Roche will provide clinical supply of atezolizumab, a PD-L1 checkpoint inhibitor.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla said it will produce ventilators at its Gigafactory in Buffalo, New York to support the city's hospitals amid the coronavirus pandemic. New York is the worst affected state in the U.S. Last Saturday, Musk tweeted that he "had a long engineering discussion with Medtronic about state-of-the-art ventilators. Luxury fashion house Ralph Lauren will donate $10 million to help fight the coronavirus pandemic and manufacture face masks as well as medical gowns in the U.S. The company's charity arm, the Ralph Lauren Corporate Foundation, said in a statement that it is committing $10 million towards the global response to the COVID-19 pandemic. General Motors Co. is delaying work on new vehicle models and is cutting pay for its executives as part of efforts to conserve cash amid the coronavirus or Covid-19 pandemic. The automotive giant also extended the shutdown of North American plants indefinitely. Multiple reports cited an internal memo that salaried workforce will have 20 percent of pay deferred starting April 1.
RELATED NEWS
Follow RTT
>